Zobrazeno 1 - 10
of 31
pro vyhledávání: '"David C. Rice"'
Autor:
Mara B. Antonoff, Song Gao, Saumil Gandhi, John V. Heymach, Arlene M. Correa, Vivek Verma, Zhongxing Liao, James W. Welsh, Ravi Rajaram, Wayne L. Hofstetter, Ritsuko Komaki, Garrett L. Walsh, Lei Feng, Joe Y. Chang, Donald A. Berry, Aileen Chen, R Sadagopan, Stephen E. McRae, Peter A Balter, Reza J. Mehran, Matthew S. Ning, Jack A. Roth, Craig DeGraaf, Steven H. Lin, Melenda Jeter, Ara A. Vaporciyan, Xiaochun Wang, Paige L. Nitsch, Michael S. O'Reilly, Quynh-Nhu Nguyen, Boris Sepesi, Julianne M. Pollard-Larkin, David C. Rice, Stephen G. Swisher, Percy Lee
Publikováno v:
Lancet Oncol
Summary Background A previous pooled analysis of the STARS and ROSEL trials showed higher survival after stereotactic ablative radiotherapy (SABR) than with surgery for operable early-stage non-small-cell lung cancer (NSCLC), but that analysis had no
Autor:
Cheuk Hong Leung, Wayne L. Hofstetter, John V. Heymach, Alexandre Reuben, Myrna C.B. Godoy, Ara A. Vaporciyan, Padmanee Sharma, Yasir Elamin, Neda Kalhor, Robert R. Jenq, Junya Fujimoto, Tina Cascone, Anne S. Tsao, William N. William, Charles Lu, Frank E. Mott, Nadim J. Ajami, Don L. Gibbons, Jack A. Roth, David C. Rice, Luisa M. Solis, Hai T. Tran, Brett W. Carter, Lauren Averett Byers, Andrew Futreal, Lorenzo Federico, Annikka Weissferdt, Garrett L. Walsh, Reza J. Mehran, Chantale Bernatchez, George R. Blumenschein, Jennifer A. Wargo, Heather Lin, Cara Haymaker, Xiuning Le, Jonathan M. Kurie, Mehmet Altan, James P. Allison, Stephen G. Swisher, Edwin R. Parra, Boris Sepesi, Hitoshi Dejima, Frank V. Fossella, Jianjun Zhang, Bonnie S. Glisson, Mara B. Antonoff, Abdul Wadud Khan, Apar Pataer, Alejandro Francisco-Cruz, Ignacio I. Wistuba, Humam Kadara, J. Jack Lee, Ferdinandos Skoulidis
Publikováno v:
Nat Med
Ipilimumab improves clinical outcomes when combined with nivolumab in metastatic non-small cell lung cancer (NSCLC), but its efficacy and impact on the immune microenvironment in operable NSCLC remain unclear. We report the results of the phase 2 ran
Autor:
Ara A. Vaporciyan, Nicolas Zhou, Caitlin Creasy, Edwin R. Parra, Ignacio I. Wistuba, Auriole Tamegnon, Cara Haymaker, Boris Sepesi, Mei Jiang, David C. Rice, Wayne L. Hofstetter, Carmelia Maria Noia Barreto, Jie Zhai, Renganayaki Krishna Pandurengan, Anne S. Tsao
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Scientific Reports
Scientific Reports
Immune profiling is becoming a vital tool for identifying predictive and prognostic markers for translational studies. The study of the tumor microenvironment (TME) in paraffin tumor tissues such as malignant pleural mesothelioma (MPM) could yield in
Autor:
Kyle G. Mitchell, Edwin R. Parra, Jiexin Zhang, David B. Nelson, Erin M. Corsini, Pamela Villalobos, Cesar A. Moran, Ferdinandos Skoulidis, Ignacio I. Wistuba, Junya Fujimoto, Jack A. Roth, Mara B. Antonoff, J. Jack Lee, Ara A. Vaporciyan, Wayne L. Hofstetter, Reza J. Mehran, Stephen G. Swisher, David C. Rice, Boris Sepesi, Garrett L. Walsh, Carmen Behrens, Neda Kalhor, Annikka Weissferdt, John V. Heymach, null AstraZeneca, null Bayer, null GlaxoSmithKline
Publikováno v:
Ann Thorac Surg
BACKGROUND: Mutations in the serine-threonine kinase LKB1/STK11 have been implicated in mediating resistance to checkpoint blockade among patients with advanced lung adenocarcinoma. We sought to examine the associations between clinicopathologic char
Autor:
Jianhua Zhang, P. Andrew Futreal, Curtis Gumbs, David C. Rice, Ignacio I. Wistuba, Alexandre Reuben, Runzhe Chen, Stephen G. Swisher, Boris Sepesi, Chi-Wan Chow, J. Jack Lee, Xin Hu, Won-Chul Lee, Hai T. Tran, John V. Heymach, Jianjun Zhang, Anne S. Tsao, Reza J. Mehran, Junya Fujimoto, Latasha Little, Cara Haymaker, Jun Li
Publikováno v:
Clin Cancer Res
Purpose:Malignant pleural mesothelioma (MPM) is considered an orphan disease with few treatment options. Despite multimodality therapy, the majority of MPMs recur and eventually become refractory to any systemic treatment. One potential mechanism und
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b3a99699a7b2f6c3b1ff29bea7ff0d6
https://europepmc.org/articles/PMC7709879/
https://europepmc.org/articles/PMC7709879/
Autor:
Lerong Li, Ismail M. Meraz, Heather Lin, Xiaobo Cao, Boris Sepesi, Jing Wang, Mourad Majidi, Lin Ji, Jack A. Roth, David C. Rice, Veerabhadran Baladandayuthapani
Publikováno v:
Cancer Immunology Research. 6:163-177
Expression of the multikinase inhibitor encoded by the tumor suppressor gene TUSC2 (also known as FUS1) is lost or decreased in non–small cell lung carcinoma (NSCLC). TUSC2 delivered systemically by nanovesicles has mediated tumor regression in cli
Autor:
Prasad S. Adusumilli, Andreas Rimner, Michelle S. Ginsberg, Anne S. Tsao, Katherine S. Panageas, W. Victoria Lai, David C. Rice, Valerie W. Rusch, Daniel R. Gomez, Lee M. Krug, Tao Dao, Marjorie G. Zauderer, Reza J. Mehran, David A. Scheinberg
Publikováno v:
Clinical Cancer Research. 23:7483-7489
Purpose: Determine the 1-year progression-free survival (PFS) rate among patients with malignant pleural mesothelioma (MPM) receiving the WT1 peptide vaccine galinpepimut-S after multimodality therapy versus those receiving control adjuvants. Experim
Autor:
Valerie W. Rusch, Ritu Gill, Alan Mitchell, David Naidich, David C. Rice, Harvey I. Pass, Hedy L. Kindler, Marc De Perrot, Joseph Friedberg, Michelle Ginsberg, Jeremy Erasmus, Samuel Armato, Christopher Strauss, Wickii Vigneshwaran, Sharyn Katz, Marc de Perrot, Demetrios Patios, Dori Giroux, Lynn Shemanski
Publikováno v:
The Annals of Thoracic Surgery. 102:1059-1066
Background Standard imaging modalities are inaccurate in staging malignant pleural mesothelioma (MPM). Single-institution studies suggest that volumetric computed tomography (CT) is more accurate but labor intensive. We established a multicenter netw
Autor:
Qing H. Meng, Boris Sepesi, Arlene M. Correa, Wayne L. Hofstetter, Vanessa B. Jensen, Garrett L. Walsh, Yi Xu, David C. Rice, Yungchang Chen, Xiaoshan Zhang, Jack A. Roth, Apar Pataer, John V. Heymach, George T. Pisimisis, Shuhong Wu, Li Wang, Chenghui Ren, Junya Fujimoto, Stephen G. Swisher, Ran Zhang, Reza J. Mehran, Mara B. Antonoff, Bingliang Fang, Ara A. Vaporciyan
Publikováno v:
Cancer
Background Patient-derived xenograft (PDX) models increasingly are used in translational research. However, the engraftment rates of patient tumor samples in immunodeficient mice to PDX models vary greatly. Methods Tumor tissue samples from 308 patie
Autor:
Pedro T. Ramirez, Barbra B. Speer, David C. Rice, Bradford J. Kim, Javier Lasala, Gabriel E. Mena, Heather A. Lillemoe, Neema Navai, Brian K. Bednarski, Thomas A. Aloia, Vijaya Gottumukkala, Rachel K. Voss, Wendell H. Williams, Rebecca K. Marcus
BACKGROUND: Enhanced recovery (ER) protocols are increasingly being utilized in surgical practice. Outside of colorectal surgery, however, their feasibility, safety, and efficacy in major oncologic surgery have not been proven. This study compared pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29af77384c9b3545b9d2e8e05535abcb
https://europepmc.org/articles/PMC6878764/
https://europepmc.org/articles/PMC6878764/